Levine M M
Rev Infect Dis. 1986 May-Jun;8 Suppl 2:S207-16. doi: 10.1093/clinids/8.supplement_2.s207.
Acute diarrheal disease may be due to viral, bacterial, or protozoal enteropathogens. In our current state of knowledge and medical practice, specific antiviral agents are not used in the treatment of known or presumed viral diarrhea. In contrast, for a number of the bacterial and protozoal diarrheal infections, therapy with certain antimicrobial agents can significantly ameliorate the severity and duration of illness and curtail the excretion of the pathogen. A recurring theme encountered in reviewing information on the therapy for diarrheal infections is that demonstration of the susceptibility in vitro of a bacterial pathogen to a particular antibiotic by no means assures clinical success. Many antibiotics that show potent activity in vitro have little or no efficacy in vivo. Controlled clinical trials are necessary to assess the clinical and bacteriologic efficacy of an antibiotic in diarrheal infections.
急性腹泻病可能由病毒、细菌或原生动物肠道病原体引起。就我们目前的知识水平和医疗实践而言,特定的抗病毒药物并不用于治疗已知或疑似的病毒性腹泻。相比之下,对于许多细菌性和原生动物性腹泻感染,使用某些抗菌药物进行治疗可显著减轻疾病的严重程度和持续时间,并减少病原体的排泄。在回顾腹泻感染治疗信息时反复出现的一个问题是,体外证明细菌病原体对特定抗生素敏感并不能保证临床治疗成功。许多在体外显示出强效活性的抗生素在体内几乎没有疗效。评估抗生素在腹泻感染中的临床和细菌学疗效需要进行对照临床试验。